Scale -


  • Revenue is 506 Rs Cr; Annual Growth is 32 %; in Bottom Quartile
  • Ebitda is 96.71 Rs Cr; Annual Growth is 165 %; in Bottom Quartile
  • PBT is 21.11 Rs Cr; Annual Growth is 652 %; in Bottom Quartile; 5 Year CAGR is -14 %
  • PAT is 42.05 Rs Cr; Annual Growth is 636 %; in Bottom Quartile; 5 Year CAGR is -19 %
  • Quarterly Revenue is 167 Rs Cr; Continuous Growth over 3 Quarters; in Bottom Quartile

Profitability -


  • PBDIT Margin is 19.11 %; Annual Growth is 100 %; 5 Year CAGR is -8 %
  • PAT Margin is 8.31 %; Annual Growth is 458 %; 5 Year CAGR is -22 %

Return -


  • ROCE is 7.57 %; Annual Growth is 536 %; 5 Year CAGR is -24 %
  • ROA is 4.18 %; Annual Growth is 515 %; 5 Year CAGR is -27 %
  • ROE is 5.37 %; Annual Growth is 597 %; 5 Year CAGR is -28 %
  • Asset Turnover is 55 %; in Bottom Quartile

Efficiency -


  • Inventory Turnover Ratio is 3.07; Continuous Growth over 3 years; in Bottom Quartile
  • Current Ratio is 1.64; Annual Decline is -41 %; Continuous Decline over 3 years
  • Quick Ratio is 0.72; Annual Decline is -47 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cash flow is 31.49 Rs Cr; in Bottom Quartile

Solvancy -


  • Contingent Liabilities is 15.52 Rs Cr; Continuous Decline over 3 years; 5 Year CAGR is -34 %
  • Long term Debt is 5.01 Rs Cr; 5 Year CAGR is -21 %
  • Debt/Equity is 0.15; Annual Growth is 200 %; Continuous Growth over 3 years
  • Total Debt is 120 Rs Cr; Annual Growth is 231 %; Continuous Growth over 3 years

Quality -


  • Change in Inventories/Total Expenses is -10 %; Annual Decline is -268 %; in Bottom Quartile
  • Operating cashflow/ebitda is 33 %; 5 Year CAGR is 17 %; Annual Decline is -52 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cashflow/PAT is 75 %; 5 Year CAGR is 37 %; Annual Decline is -83 %; in Bottom Quartile
  • Current Tax/PAT is 28 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Other Expenses/Total Expenses is 28 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Broker Revenue Forecasts For Tatva Chintan Pharma Chem Limited (NSE:TATVA) Are Surging Higher
Tatva Chintan Pharma Chem Limited Estimates – NSE:TATVA